Patent directory · USPTO A61K / A61P
Patents matching “treatment”
2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12410240
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
granted -
US 12404337
Compositions, doses, and methods for treatment of thyroid eye disease
granted -
US 12403202
Dosage of claudin-6 conjugates for cancer treatment
granted -
US 12404335
Compositions and methods for treatment of thyroid eye disease
granted -
US 12396974
Ketone ester as a therapeutic treatment of Covid-19 and related viral infections
granted -
US 12396988
Methods of using muscarinic antagonists in the treatment of depression
granted -
US 12397066
Delivery of gene therapy treatments
granted -
US 12396991
Biomarkers for the diagnosis and treatment of fibrotic lung disease
granted -
US 12391720
Salts and polymorphs of cethromycin for the treatment of disease
granted -
US 12383567
Use of cannabinoids in the treatment of epilepsy
granted -
US 12383585
Methods of treatment of infections using bacteria
granted -
US 12384762
Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
granted -
US 12383545
TREATMENT OF MIGRAINE
granted -
US 12377115
Combination immunotherapies for treatment of cancer
granted -
US 12378557
Treatment of sepsis with PCSK9 and LDLR modulators
granted -
US 12377102
Compounds for the prevention and treatment of medical disorders and uses thereof
granted -
US 12370256
Activation of resident memory T cells for the treatment of cancer
granted -
US 12370241
Nasal powder formulation for treatment of hypoglycemia
granted -
US 12371503
Methods of treatment using a leptin receptor agonist antibody
granted -
US 12370195
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions
granted -
US 12365659
Non-polyamine based polyamine transport inhibitors and their use in the treatment of human cancers
granted -
US 12364668
Treatment of opioid use disorder, opioid withdrawal symptoms, and chronic pain
granted -
US 12364765
Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria
granted -
US 12365719
CD80 extracellular domain polypeptides and their use in cancer treatment
granted